Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Memorial Sloan Kettering Cancer Center
Baylor College of Medicine
Columbia University
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
University of California, San Francisco
Columbia University
Wake Forest University Health Sciences
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
Hamad Medical Corporation
Ann & Robert H Lurie Children's Hospital of Chicago